These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 16621538)
1. Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidol. Ablordeppey SY; Lyles-Eggleston M; Bricker B; Zhang W; Zhu X; Goodman C; Roth BL Bioorg Med Chem Lett; 2006 Jun; 16(12):3219-23. PubMed ID: 16621538 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol. Peprah K; Zhu XY; Eyunni SV; Etukala JR; Setola V; Roth BL; Ablordeppey SY Bioorg Med Chem; 2012 Mar; 20(5):1671-8. PubMed ID: 22336245 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and evaluation of metabolism-based analogues of haloperidol incapable of forming MPP+-like species. Lyles-Eggleston M; Altundas R; Xia J; Sikazwe DM; Fan P; Yang Q; Li S; Zhang W; Zhu X; Schmidt AW; Vanase-Frawley M; Shrihkande A; Villalobos A; Borne RF; Ablordeppey SY J Med Chem; 2004 Jan; 47(3):497-508. PubMed ID: 14736232 [TBL] [Abstract][Full Text] [Related]
4. Rational design, synthesis and evaluation of (6aR( *),11bS( *))-1-(4-fluorophenyl)-4-{7-[4-(4-fluorophenyl)-4-oxobutyl]1,2,3,4,6,6a,7,11b,12,12a(RS)-decahydropyrazino[2',1':6,1]pyrido[3,4-b]indol-2-yl}-butan-1-one as a potential neuroleptic agent. Chakrabarty R; Rao J; Anand A; Roy AD; Roy R; Shankar G; Dua PR; Saxena AK Bioorg Med Chem; 2007 Dec; 15(23):7361-7. PubMed ID: 17869521 [TBL] [Abstract][Full Text] [Related]
5. Identification of a butyrophenone analog as a potential atypical antipsychotic agent: 4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one. Ablordeppey SY; Altundas R; Bricker B; Zhu XY; Kumar EV; Jackson T; Khan A; Roth BL Bioorg Med Chem; 2008 Aug; 16(15):7291-301. PubMed ID: 18595716 [TBL] [Abstract][Full Text] [Related]
6. SYA 013 analogs as moderately selective sigma-2 (σ Al-Ghanim L; Zhu XY; Asong G; Ablordeppey SY Bioorg Med Chem; 2019 Jun; 27(12):2421-2426. PubMed ID: 30737135 [TBL] [Abstract][Full Text] [Related]
7. Further evaluation of the tropane analogs of haloperidol. Sampson D; Bricker B; Zhu XY; Peprah K; Lamango NS; Setola V; Roth BL; Ablordeppey SY Bioorg Med Chem Lett; 2014 Sep; 24(17):4294-7. PubMed ID: 25070422 [TBL] [Abstract][Full Text] [Related]
8. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum. Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition. Mihara T; Mihara K; Yarimizu J; Mitani Y; Matsuda R; Yamamoto H; Aoki S; Akahane A; Iwashita A; Matsuoka N J Pharmacol Exp Ther; 2007 Nov; 323(2):708-19. PubMed ID: 17684118 [TBL] [Abstract][Full Text] [Related]